Kineret or anakinra
Complete list of drugs used to
treat arthritis.
Kineret or anakinra is the first direct and selective blocker of interleukin-1 (IL-1),
a protein seen in excess in patients with rheumatoid arthritis. By blocking IL-1,
Kineret® inhibits the inflammatory response in rheumatoid arthritis.
General Information about Kineret or anakinra
Kineret is an injectable therapy approved for the treatment of signs and symptoms of
rheumatoid arthritis (RA), in adults who have failed one or more disease modifying
antirheumatic drugs (DMARDs). The drug is administered once-daily through subcutaneous
injection.
RA is a disabling condition that causes pain, swelling and severe limitations of
movement. Joint inflammation can destroy cartilage, tendons and ligaments, wear away bone
and subsequently cause joint deformity. While RA can affect people at any age, it occurs
most commonly in individuals ages 25 - 50.
How taken to take Kineret or anakinra
Daily subcutaneous (under the skin) injections by the patient or health care provider
Side effects of Kineret or anakinra
- redness, swelling, bruising, or pain at the site of injection
- headache
- upset stomach
- diarrhea
- runny nose
- stomach pain
Some side effects can be serious. The following symptoms are uncommon,
but if you experience any of them , call your doctor immediately:
- rash
- flu-like symptoms
- fever, sore throat, chills, and other signs of infection
- coughing, wheezing, or chest pain
- hot, red, swollen area on the skin
|
